Dr. Raphael is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4915 Auburn Ave
Suite 202
Bethesda, MD 20814Phone+1 301-907-3442Fax+1 301-907-6835
Education & Training
- National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 1984 - 1989
- Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 1981 - 1984
- Emory University School of MedicineClass of 1981
Certifications & Licensure
- MD State Medical License 1983 - 2025
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 37 citationsLong-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis.Paul Chervinsky, Sudeesha Kunjibettu, David L. Miller, Bruce M. Prenner, Gordon D. Raphael
Annals of Allergy, Asthma & Immunology. 2007-07-01 - 6 citationsTwelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma.Gordon D. Raphael, Herminia Taveras, Harald Iverson, C.D. O'Brien, David Miller
The Journal of Asthma. 2016-02-07 - 19 citationsEfficacy and tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis.Dale Mohar, William E. Berger, Craig LaForce, Gordon Raphael, S.Y. Desai
Allergy and Asthma Proceedings. 2012-01-01
Press Mentions
- Novel Fluticasone Propionate MDPI Improves Quality of Life, Asthma SymptomsMarch 4th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: